BIOSPECIFICS TECHNOLOGIES CO
CUSIP 090931106
Biospecifics Technologies Co has 91 institutional holders in Filings Flow’s 13F database, together reporting 2.24M shares worth $179M as of Q3 2019.
Institutional Holders
91
Q3 2019
Reported Value
$179M
Ticker
unmapped
private placement or foreign
Quarters Tracked
4
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| Federation des caisses Desjardins du Quebec$27.8B AUM | 0.01% | $329,513 | 6.0K | Q2 2024 |
| MetLife Investment Management, LLC$19.6B AUM | 0.00% | $185,985 | 3.0K | Q1 2024OLDER |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.